The Effect of Progressive Relaxation Exercise on Nurses

NCT ID: NCT06071169

Last Updated: 2023-10-06

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

60 participants

Study Classification

INTERVENTIONAL

Study Start Date

2023-10-23

Study Completion Date

2023-11-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study aims to examine the effect of progressive relaxation exercise on nurses' life satisfaction, comfort and burnout levels. Data will be collected by using Descriptive Characteristics Information Form, Satisfaction with Life Scale, Nurse Comfort Scale and Burnout Scale. The nurses in the intervention group will be asked to perform relaxation exercises. The nurses in the control group will not receive any intervention.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This study aims to examine the effect of progressive relaxation exercise on nurses' life satisfaction, comfort and burnout levels. This study will be conducted as a randomized controlled experimental study. Data will be collected by using Descriptive Characteristics Information Form, Satisfaction with Life Scale, Nurse Comfort Scale and Burnout Scale. The nurses in the intervention group will be asked to perform relaxation exercises 3 days a week for 5 weeks, 20 minutes in each practice. The nurses in the control group will not receive any intervention.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Progressive Relaxation Exercise Comfort Life Satisfaction Burnout

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

SUPPORTIVE_CARE

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Intervention

progressive relaxation exercise group The nurses will perform the relaxation exercises 3 days a week for 5 weeks, 20 minutes in each practice.

Group Type EXPERIMENTAL

progressive relaxation exercise

Intervention Type OTHER

Nurses will be asked to perform relaxation exercises 3 days a week for 5 weeks, 20 minutes in each practice.

Control

Control group No application has been made.

Group Type NO_INTERVENTION

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

progressive relaxation exercise

Nurses will be asked to perform relaxation exercises 3 days a week for 5 weeks, 20 minutes in each practice.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

Working as a nurse in a tertiary treatment center for at least 3 years Have not participated in any relaxation exercise Absence of neurological/psychiatric disorders Not having an obstacle to exercise Nurses who volunteered to participate in the study will be included in the study.

Exclusion Criteria

Individuals who have any exercise program and use any relaxation method (yoga, acupuncture, massage, music therapy, etc.) will not be included in the study.
Minimum Eligible Age

18 Years

Maximum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

TC Erciyes University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Sevda Korkut

Instructor

Responsibility Role PRINCIPAL_INVESTIGATOR

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

47/2023

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.